Effect of the 3q26-coding oncogene SEC62 as a potential prognostic marker in patients with ovarian neoplasia

Effect of the 3q26-coding oncogene SEC62 as a potential prognostic marker in patients with ovarian neoplasia

With approximately 220,000 newly diagnosed cases per year, ovarian cancer is among the most frequently occurring cancers among women and the second leading cause of death from gynecological malignancies worldwide. About 70% of these cancers are diagnosed in advanced stages (FIGO IIB–IV), with a 5-ye...

Full description

Bibliographic Details
Main Authors: Julia C. Radosa, Mariz Kasoha, Anne-Christine Schilz, Zoltan F. Takacs, Askin Kaya, Marc P. Radosa, Barbara Linxweiler, Maximilian Linxweiler, Rainer M. Bohle, Mathias Wagner, Gudrun Wagenpfeil, Erich-Franz Solomayer, Julia S. M. Zimmermann
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Physiology
Subjects:
Sec62
prognostic
therapy
ovarian cancer
borderline tumors of the ovary
tumor driver mutation
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2022.1054508/full

Internet

https://www.frontiersin.org/articles/10.3389/fphys.2022.1054508/full

Similar Items